Answer
These treatments may increase bleeding risk. The cancer team must assess concurrent use, and warfarin or other vitamin K antagonists should not be given with acalabrutinib.
Sources for this answer
- Calquence 100 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.